View |
|
DR-XY43895
|
Cefpirome (as sulfate)
|
Zefrome
|
1g
|
Powder For Injection (Iv)
|
-
|
Sichuan Pharmaceutical Inc.
|
China
|
-
|
03 January 2020
|
19 December 2024
|
View |
|
DR-XY43897
|
Ketorolac Trometamol
|
Ketorobas
|
30 mg/Ml
|
Solution For Injection (I.M./I.V.)
|
-
|
Friends Pharma (Pvt) Ltd.
|
Pakistan
|
-
|
24 June 2020
|
26 November 2024
|
View |
|
DR-XY43898
|
Renal Pure
|
Sodium Bicarbonate + Sodium Chloride
|
627g/224g
|
Powder for Hemodialysis Solutiion
|
-
|
Rockwell Medical
|
U.S.A.
|
-
|
07 February 2020
|
13 November 2024
|
View |
|
DR-XY43899
|
Paracetamol
|
Paragesic
|
500 mg
|
Suppository
|
-
|
Bliss GVS Pharma Ltd.
|
India
|
-
|
05 September 2019
|
13 November 2024
|
View |
|
DR-XY43902
|
Aceclofenac + Paracetamol
|
Dolowin Plus
|
100mg / 500mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory Drug/Analgesic/
Antipyretic
|
Micro Labs Limited
|
India
|
Monitored Release
|
04 February 2022
|
21 November 2024
|
View |
|
DR-XY43904
|
Multivitamins + Iron + Citrus Bioflavonoids Extract
|
Fumiron + B
|
6mg, 6mg, 5mg, 1mg, 50mcg, 75mg, 100mg, 25mg
|
Softgel Capsules
|
-
|
Catalent Australia Pty Ltd
|
Australia
|
-
|
23 December 2019
|
21 November 2024
|
View |
|
DR-XY43906
|
Imipenem + Cilastatin Sodium
|
BDIMI-C 500
|
500 mg/ 500 mg
|
Powder For Injection (I.V.)
|
-
|
Mepromax Lifesciences Pvt. Ltd.
|
India
|
-
|
29 November 2019
|
20 November 2024
|
View |
|
DR-XY43907
|
Imipenem + Cilastatin Sodium
|
Bdimi-C 250
|
250 mg / 250
|
Powder for Injection (I.V.)
|
-
|
Mepromax Lifesciences Pvt. Ltd
|
|
-
|
28 August 2019
|
20 November 2024
|
View |
|
DR-XY43908
|
Amino Acids
|
Aminosil
|
5.4% w/v
|
Solution For Iv Infusion
|
-
|
Dai Han Pharm. Co., Ltd.
|
Korea
|
-
|
13 March 2020
|
20 November 2024
|
View |
DR-XY43909_PI_01.pdf
|
DR-XY43909
|
Verapamil Hydrochloride
|
Isoptin
|
2.5mg/mL (5mg/2mL)
|
Solution For IV Injection
|
-
|
Famar Health Care Services Madrid S.A.U.
|
Spain
|
-
|
20 December 2019
|
20 November 2024
|
View |
|
DR-XY43911
|
Cinacalcet (as hydrochloride)
|
Calcipar
|
30 mg
|
Film-Coated Tablet
|
Anti-parathyroid Agent
|
Ind-Swift Limited
|
India
|
Monitored Release
|
25 March 2022
|
24 November 2024
|
View |
|
DR-XY43912
|
Celecoxib
|
Rifoxib
|
200 mg
|
Capsule
|
-
|
Lloyd Laboratores, Inc.
|
Philippines
|
-
|
27 May 2020
|
01 December 2024
|
View |
|
DR-XY43913
|
Ranolazine
|
Ranexa
|
750mg
|
Prolonged-Release Tablet
|
-
|
Menarini- Von Heyden GmbH
|
Germany
|
Initial (from Monitored Release)
|
12 April 2022
|
21 November 2024
|
View |
|
DR-XY43914
|
Ranolazine
|
Ranexa
|
500mg
|
Prolonged-Release Tablet
|
-
|
Menarini- Von Heyden GmbH
|
Germany
|
-
|
11 April 2022
|
21 November 2024
|
View |
|
DR-XY43915
|
Ranolazine
|
Ranexa
|
375mg
|
Prolonged-Release Tablet
|
-
|
Menarini- Von Heyden GmbH
|
Germany
|
-
|
11 April 2022
|
21 November 2024
|
View |
|
DR-XY43916
|
Clobetasol Propionate
|
None
|
500mcg/ g (0.05%w/w)
|
Cream
|
Anti-inflammatory/Anti-pruritic
|
DS Cosmeceutical Manufacturing Laboratory
|
Philippines
|
Automatic Renewal
|
15 September 2021
|
25 November 2026
|
View |
|
DR-XY43917
|
Celecoxib
|
Celtrix
|
200 mg
|
Capsule
|
-
|
Lloyd Laboratories Inc.
|
Philippines
|
-
|
05 December 2019
|
21 November 2024
|
View |
|
DR-XY43919
|
Atorvastatin (as calcium)
|
Caliptrol
|
20 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Ferozsons Laboratories, Limited
|
Pakistan
|
Renewal
|
25 July 2024
|
21 November 2029
|
View |
|
DR-XY43920
|
Atorvastatin (as calcium)
|
Caliptrol
|
10 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Ferozsons Laboratories, Limited
|
Pakistan
|
Renewal
|
04 August 2024
|
21 November 2029
|
View |
|
DR-XY43921
|
Atorvastatin (As Calcium)
|
Caliptrol
|
40 mg
|
Film-Coated Tablet
|
Antihyperlipidemic
|
Ferozsons Laboratories, Limited
|
Pakistan
|
-
|
17 January 2020
|
21 November 2024
|